株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

避妊薬・避妊具の世界市場:製品・エンドユーザー・地域別の予測

Contraceptives Market - Forecast (2020 - 2025)

発行 IndustryARC 商品コード 422706
出版日 ページ情報 英文 100 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.95円で換算しております。
避妊薬・避妊具の世界市場:製品・エンドユーザー・地域別の予測 Contraceptives Market - Forecast (2020 - 2025)
出版日: 2020年03月11日 ページ情報: 英文 100 Pages
概要

当レポートでは、避妊薬・避妊具の世界市場について調査し、製品、エンドユーザー、地域別の市場動向および市場成長予測、市場の促進・抑制要因、市場の機会・課題、戦略分析、主要企業のプロファイルなどをまとめています。

第1章 市場概要

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場シェア分析
  • 比較分析
  • 製品ベンチマーク
  • エンドユーザーのプロファイル
  • トップ5社の財務分析

第4章 市場力学

  • 市場の促進要因
  • 市場の抑制要因
  • 市場の機会
  • 市場の課題
  • ファイブフォース分析

第5章 避妊薬・避妊具の世界市場:戦略分析

  • バリューチェーン分析
  • 価格分析
  • 市場機会分析
  • 製品/市場のライフサイクル分析
  • 供給・流通

第6章 避妊薬・避妊具の世界市場:製品別

  • 避妊薬
    • 経口避妊薬
    • 注射避妊薬
    • 局所避妊薬
  • 避妊具
    • コンドーム
    • ペッサリー
    • スポンジ
    • 避妊リング
    • インプラント
    • 子宮内避妊器具(IUD)

第7章 避妊薬・避妊具の世界市場:エンドユーザー別

  • 病院
  • 診療所
  • 在宅ケア
  • 外来手術センター(ASC)
  • その他

第8章 避妊薬・避妊具の世界市場:地域別

  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • 英国
    • その他の国々
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他の国々
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • その他の地域
    • ブラジル
    • その他の国々

第9章 避妊薬・避妊具の世界市場:エントロピー

  • 市場の拡大
  • 技術の進歩
  • 合併・買収・合弁事業
  • 供給契約

第10章 企業プロファイル

第11章 付録

目次
Product Code: HCR 0411

Contraceptives Market Overview:

According to the Guttmacher Institute Organization, an estimated 44% of pregnancies globally were unintended and 56% of unwanted pregnancies ended in abortion at the initial phase of this decade.[1] Such peculiar cases amalgamated with increasing instances of sexually transmitted diseases (STIs) are significantly boosting the contraceptives market. As per the WHO, more than 1 million STIs are acquired every day globally, and 988,000 pregnant women were infected with syphilis (a form of STI) in 2016, resulting in over 200,000 stillbirths and newborn deaths.[2] All these factors coupled with rapidly increasing global population and governmental measures to counter population tumor are propelling contraceptives market growth. The global contraceptives market is estimated to be around $20 billion-$21 billion as of 2018. Increasing awareness among women in developed as well as rural areas of developing countries such as India and Africa regarding HIV, STIs, fertility control and birth-control is propelling this arcade to be progressing at a CAGR of 6%-7% during the forecast period of 2019-2025.

Contraceptives Market Outlook:

Contraception can be defined as the deliberate inhibition of pregnancy by interfering with the biological process of ovulation, fertilization and implantation through the use of barriers, drugs, medical devices or surgical techniques and the devices used for contraception are called as contraceptives. Contraceptives drugs or devices not only inhibit pregnancy but also sexually transmitted diseases (STDs).

In the products segment of the contraceptive market, Intrauterine Devices (IUD) secures the dominant spot and is progressing with an application CAGR of 30% - 35% going through 2025. Its supremacy above several other wide ranges of devices such as contraceptive sponges, vaginal rings, contraceptive diaphragms, subdermal implants, male condoms and female condoms can be attributed to its efficacy in prevention of unwanted pregnancies. According to the findings of the American Pregnancy Association, the intrauterine system has a failure rate of less than 1%.[3]

After an acute region-wise analysis of the global contraceptive market, North America is detected to be the dominant region. This region is responsible for nearly 28% - 30% of the global contraceptives market demand. With more than 50% of the population dominated by women, the United States is the most lucrative marketplace for contraceptives in North America. Also, United States median age is recorded to be around 37 years[4], thus indicating half of the population to be young and sexually active (below 37 years) and major consumers of contraceptives drugs and devices.

Contraceptives Market Growth Drivers and Trends:

A huge chunk of the female population in developing countries are diverting towards ideology such as women empowerment and feminism to establish educational and professional opportunities for women. An increasing number of women are delaying motherhood with the help of contraceptive devices and drugs as they prioritize their careers. Women comprised 47 percent of the total U.S. labor force at the initial phase of this decade. This is a major trend disrupting the global contraceptives market. Such assertions can meet confirmation with facts from the United States Department of Labor stating that 57% of women participate in the labor force and 26% of professionals employed computer and mathematical occupations are women.[5] Women are projected to account for 51 percent of the increase in total labor force growth between 2008 and 2018.[6]

Severe government regulations to control alarming population growth in some densely populated economies are serving as a major trend for the contraceptives market. An example can be derived from APAC, China. The family planning policy in China by the government allows only two children per couple since 2016. Enforcement requires women to have a contraceptive intrauterine device (IUD) surgically installed after having a first child, and to be sterilized by tubal ligation after having a second child. Thus nearly 667 million women in China are inevitably potential customers for the contraceptives market.

Contraceptives Market Challenges:

Lack of awareness and acceptance of contraceptives are the major factors hindering the market growth coupled with continuous and expensive necessary cycles for effective birth control. Hormonal contraceptives contain hormones such as estrogen and progestin, with side effects such as weight gain, headaches, sore breasts, irregular periods, mood changes, acne, and nausea.

Contraceptives Market

Contraceptives Market Players Perspective:

Some of the major players controlling majority of the global market share are Cooper Surgical, Inc. (U.S.), Pfizer, Inc. (U.S.), Actavis, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Bayer AG (Germany), The Female Health Company (U.S.), Merck & Co., Inc. (U.S.), Mayer Laboratories, Inc. (U.S.), Church & Dwight, Co., Inc. (U.S.), and Medisafe Distribution Inc. (Canada).

Teva Pharmaceutical Industries Limited is one of the leading manufacturing establishment pertaining to contraceptives. It acquired Theramex and related companies from Merck Serono. As Theramex offers a wide variety of women's health products sold in 50 countries worldwide, this merger will open up more avenues for profits and revenue.

Contraceptives Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Contraceptives Market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the various drugs and devices in Contraceptives Market and their specific biological uses.

Contraceptives Market Report: Industry Coverage

By Product: Drug, Devices

By End-User: Hospital, Clinic, Home Care, Ambulatory Surgical Centre

The Contraceptives Market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia

A few focus points of this Research are given below:

Give a deep-dive analysis of the key operational strategies with a focus on the corporate structure, R&D strategies, localization strategies, production capabilities, and sales performance of various companies

Provide an overview of the product portfolio, including product planning, development, and positioning

Discuss the role of technology companies in partnerships

Explore the regional sales activities

Analyze the market size and giving the forecast for current and future Contraceptives Market during the forecast 2019-2025

Analyze the competitive factors, competitors' market shares, product capabilities, and supply chain structures.

1. Contraceptives Market - Overview

  • 1.1. Definitions and Scope

2. Contraceptives Market - Executive summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends by type of Application
  • 2.3. Key Trends segmented by Geography

3. Contraceptives Market

  • 3.1. Comparative analysis
    • 3.1.1. Product Benchmarking - Top 10 companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value split by Top 10 companies
    • 3.1.4. Patent Analysis - Top 10 companies
    • 3.1.5. Pricing Analysis

4. Contraceptives Market Forces

  • 4.1. Drivers
  • 4.2. Constraints
  • 4.3. Challenges
  • 4.4. Porters five force model
    • 4.4.1. Bargaining power of suppliers
    • 4.4.2. Bargaining powers of customers
    • 4.4.3. Threat of new entrants
    • 4.4.4. Rivalry among existing players
    • 4.4.5. Threat of substitutes

5. Contraceptives Market -Strategic analysis

  • 5.1. Value chain analysis
  • 5.2. Opportunities analysis
  • 5.3. Product life cycle
  • 5.4. Suppliers and distributors Market Share

6. Contraceptives Market - By Product (Market Size -$Million / $Billion)

  • 6.1. Market Size and Market Share Analysis
  • 6.2. Application Revenue and Trend Research
  • 6.3. Product Segment Analysis
    • 6.3.1. Drug
      • 6.3.1.1. Oral Contraceptive
      • 6.3.1.2. Injectible
      • 6.3.1.3. Topical
    • 6.3.2. Devices
      • 6.3.2.1. Condom
      • 6.3.2.2. Diaphragms
      • 6.3.2.3. Sponges
      • 6.3.2.4. Vaginal Ring
      • 6.3.2.5. Subdermal Implants
      • 6.3.2.6. Intrauterine Devices
      • 6.3.2.6.1. Male
      • 6.3.2.6.2. Female

7. Contraceptives - By End-User(Market Size -$Million / $Billion)

  • 7.1. Segment type Size and Market Share Analysis
  • 7.2. Application Revenue and Trends by type of Application
  • 7.3. Application Segment Analysis by Type
    • 7.3.1. Hospital
    • 7.3.2. Clinic
    • 7.3.3. Home Care
    • 7.3.4. Ambulatory Surgical Centre
    • 7.3.5. Others

8. Contraceptives - By Geography (Market Size -$Million / $Billion)

  • 8.1. Contraceptives Market - North America Segment Research
  • 8.2. North America Market Research (Million / $Billion)
    • 8.2.1. Segment type Size and Market Size Analysis
    • 8.2.2. Revenue and Trends
    • 8.2.3. Application Revenue and Trends by type of Application
    • 8.2.4. Company Revenue and Product Analysis
    • 8.2.5. North America Product type and Application Market Size
      • 8.2.5.1. U.S.
      • 8.2.5.2. Canada
      • 8.2.5.3. Mexico
      • 8.2.5.4. Rest of North America
  • 8.3. Contraceptives - South America Segment Research
  • 8.4. South America Market Research (Market Size -$Million / $Billion)
    • 8.4.1. Segment type Size and Market Size Analysis
    • 8.4.2. Revenue and Trends
    • 8.4.3. Application Revenue and Trends by type of Application
    • 8.4.4. Company Revenue and Product Analysis
    • 8.4.5. South America Product type and Application Market Size
      • 8.4.5.1. Brazil
      • 8.4.5.2. Venezuela
      • 8.4.5.3. Argentina
      • 8.4.5.4. Ecuador
      • 8.4.5.5. Peru
      • 8.4.5.6. Colombia
      • 8.4.5.7. Costa Rica
      • 8.4.5.8. Rest of South America
  • 8.5. Contraceptives - Europe Segment Research
  • 8.6. Europe Market Research (Market Size -$Million / $Billion)
    • 8.6.1. Segment type Size and Market Size Analysis
    • 8.6.2. Revenue and Trends
    • 8.6.3. Application Revenue and Trends by type of Application
    • 8.6.4. Company Revenue and Product Analysis
    • 8.6.5. Europe Segment Product type and Application Market Size
      • 8.6.5.1. U.K
      • 8.6.5.2. Germany
      • 8.6.5.3. Italy
      • 8.6.5.4. France
      • 8.6.5.5. Netherlands
      • 8.6.5.6. Belgium
      • 8.6.5.7. Spain
      • 8.6.5.8. Denmark
      • 8.6.5.9. Rest of Europe
  • 8.7. Contraceptives - APAC Segment Research
  • 8.8. APAC Market Research (Market Size -$Million / $Billion)
    • 8.8.1. Segment type Size and Market Size Analysis
    • 8.8.2. Revenue and Trends
    • 8.8.3. Application Revenue and Trends by type of Application
    • 8.8.4. Company Revenue and Product Analysis
    • 8.8.5. APAC Segment - Product type and Application Market Size
      • 8.8.5.1. China
      • 8.8.5.2. Australia
      • 8.8.5.3. Japan
      • 8.8.5.4. South Korea
      • 8.8.5.5. India
      • 8.8.5.6. Taiwan
      • 8.8.5.7. Malaysia

9. Contraceptives Market - Entropy

  • 9.1. New product launches
  • 9.2. M&A's, collaborations, JVs and partnerships

10. Contraceptives Market Company Analysis

  • 10.1. Market Share, Company Revenue, Products, M&A, Developments
  • 10.2. Cooper Surgical, Inc.
  • 10.3. Bayer AG
  • 10.4. Actavis, Inc.
  • 10.5. The Female Health Company
  • 10.6. Merck & Co., Inc.
  • 10.7. Mayer Laboratories, Inc
  • 10.8. Pfizer, Inc.
  • 10.9. Church & Dwight, Co., Inc.
  • 10.10. Medisafe Distribution Inc
  • 10.11. Teva Pharmaceutical Industries Limited
  • 10.12. Company 11
  • 10.13. Company 12
  • 10.14. Company 13 and more

"*Financials would be provided on a best efforts basis for private companies"

11. Contraceptives Market - Appendix

  • 11.1. Abbreviations
  • 11.2. Sources

12. Contraceptives Market - Methodology

  • 12.1. Research Methodology
    • 12.1.1. Company Expert Interviews
    • 12.1.2. Industry Databases
    • 12.1.3. Associations
    • 12.1.4. Company News
    • 12.1.5. Company Annual Reports
    • 12.1.6. Application Trends
    • 12.1.7. New Products and Product database
    • 12.1.8. Company Transcripts
    • 12.1.9. R&D Trends
    • 12.1.10. Key Opinion Leaders Interviews
    • 12.1.11. Supply and Demand Trends